Modern Chinese Medicine Group Co (HKSE:01643) ROCE %: -7.03% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01643 Modern Chinese Medicine Group Co Ltd HKSE:01643
53 GF Score
Price HK$0.94
GF Value HK$0.16
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Modern Chinese Medicine Group Co ROCE %?

Modern Chinese Medicine Group Co HKSE:01643 -2.08% 53 ROCE % is -7.03% as of Dec. 2025. GuruFocus rates HKSE:01643 with a GF Score™ of 53/100 and a GF Value™ of HK$0.16 (Significantly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Modern Chinese Medicine Group Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -7.03%.

Modern Chinese Medicine Group Co  (HKSE:01643) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Modern Chinese Medicine Group Co ROCE % Related Terms

Modern Chinese Medicine Group Co ROCE % Historical Data

* Premium members only.

The historical data trend for Modern Chinese Medicine Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Chinese Medicine Group Co ROCE % Chart

Modern Chinese Medicine Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only 48.83 31.16 14.90 3.02 -2.86

Modern Chinese Medicine Group Co Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.38 -1.80 7.91 1.41 -7.03
HKSE:01643
53GF Score
Modern Chinese Medicine Group Co Ltd HKSE:01643
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modern Chinese Medicine Group Co ROCE % Calculation

Modern Chinese Medicine Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-15.483/( ( (576.872 - 52.273) + (600.307 - 42.839) )/ 2 )
=-15.483/( (524.599+557.468)/ 2 )
=-15.483/541.0335
=-2.86 %

Modern Chinese Medicine Group Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-38.55/( ( (582.218 - 43.648) + (600.307 - 42.839) )/ 2 )
=-38.55/( ( 538.57 + 557.468 )/ 2 )
=-38.55/548.019
=-7.03 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -7.03% mean?
Modern Chinese Medicine Group Co (HKSE:01643) has a ROCE % of -7.03% as of Dec. 2025.
Is Modern Chinese Medicine Group Co's ROCE % too high?
Modern Chinese Medicine Group Co's current ROCE % is -7.03%. Overall, Modern Chinese Medicine Group Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Modern Chinese Medicine Group Co's ROCE % compare to LLY and JNJ?
Modern Chinese Medicine Group Co's ROCE % of -7.03% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.04, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Chinese Medicine Group Co's current ROCE % is -7.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Chinese Medicine Group Co stock overvalued right now?
Based on GuruFocus' analysis, Modern Chinese Medicine Group Co (HKSE:01643) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.94 — trading 487.5% above its estimated fair value. The current ROCE % is -7.03%. Modern Chinese Medicine Group Co's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Modern Chinese Medicine Group Co (HKSE:01643), the current ROCE % is -7.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Modern Chinese Medicine Group Co (HKSE:01643) Overvalued in 2026?

Based on GuruFocus' analysis, Modern Chinese Medicine Group Co stock appears to be overvalued. The current stock price of HK$0.94 is trading 487.5% above its estimated GF Value™ of HK$0.16. GuruFocus considers Modern Chinese Medicine Group Co to be Significantly Overvalued.

Key valuation signals for HKSE:01643:

  • ROCE %: -7.03%
  • GF Value™: HK$0.16 vs. price of HK$0.94 (487.5% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the HKSE:01643 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Modern Chinese Medicine Group Co Business Description

Address No. 88 Jinwei Road, Hebei Province, Longhua County, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills, among others. Geographically, the company derives its key revenue from the People's Republic of China.
53GF Score

Get the complete analysis for HKSE:01643

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.94
Price
HK$0.16
GF Value